Belite Bio, Inc (BLTE) Tops Q4 EPS by 5c

Belite Bio, Inc (NASDAQ: BLTE) reported Q4 EPS of ($0.25), $0.05 better than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Belite Bio, Inc (BLTE) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
• Ennis (EBF) Reports In-Line Q1 EPS